A new retrospective audit of 143 patients treated for acute renal colic at North Cumbria Integrated Care NHS Foundation Trust reveals a 93.7% success rate for conservative stone management, though adherence to national guidelines for specific medications remains mixed. Published as data covering cases from January to December 2025, the findings show that while non-steroidal anti-inflammatory drugs and tamsulosin were frequently underprescribed relative to National Institute for Health and Care Excellence benchmarks, stone size emerged as the sole reliable predictor of treatment outcome.
North Cumbria Audit Tracks 143 Renal Colic Cases
Conservative therapy remains the preferred first-line approach for small, uncomplicated calculi, sparing patients from surgical morbidities and anesthesia risks. The audit evaluated adult patients presenting to the emergency department with acute ureteric stones who were offered conservative management during 2025. Out of 143 patients evaluated at North Cumbria Integrated Care NHS Foundation Trust, 101 were male (70.63%) and 42 were female (29.37%), with an average age of roughly 48 years. Eighty patients presented with stones measuring less than 5mm, while 61 patients had stones measuring between 5mm and 10mm. Only two patients with stones exceeding 10mm opted for conservative observation.
Guideline Adherence Shows Gaps in Medication Delivery
NICE guidelines recommend non-steroidal anti-inflammatory drugs as first-line analgesia alongside tamsulosin for patients with stones under 10mm located in the distal ureter. During the audit period, clinicians administered non-steroidal anti-inflammatory drugs to 103 patients, or 72% of the cohort, at presentation. However, medical expulsive therapy using tamsulosin was prescribed to just 49 of the eligible patients with distal ureteric stones, accounting for 34.3% of that subgroup. Seventeen patients, representing 11.9% of the total cohort, subsequently re-presented to the emergency department with recurring colic. Of those re-presenting patients, eight achieved successful passage through continued observation, while nine required emergency interventions, including eight ureteric stent insertions and one ureteroscopy.
Stone Size Drives Outcomes While Lab Markers Fall Short
Statistical analysis demonstrated that stone size was the only variable significantly associated with the success or failure of conservative treatment. Conversely, laboratory and radiological markers—including C-reactive protein, white blood cell count, serum creatinine, perinephric stranding, and stone position—showed no significant statistical association with whether a stone passed spontaneously. While inflammatory markers remain essential for identifying septic emergencies requiring urgent surgical decompression, the data indicates they do not reliably predict the mechanical likelihood of a sterile calculus clearing the ureteral lumen.
Common Questions About Ureteric Stone Management
What success rate did the North Cumbria audit find for conservative management?
The retrospective audit recorded a 93.7% success rate for patients managed conservatively, with 134 out of 143 individuals successfully passing their stones without primary surgery.
Which clinical factor best predicted whether a stone would pass?
Stone size was the only variable that showed a statistically significant association with the outcome of conservative treatment among the 143 patients evaluated in the 2025 audit.
How frequently were recommended medications prescribed to patients?
Clinicians administered non-steroidal anti-inflammatory drugs to 72% of the patients at presentation, while tamsulosin was prescribed to 34.3% of eligible patients with distal ureteric stones.
Worth a look